You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Laryngeal Carcinoma Trial in Dallas (LT-SABR, IMRT)

Not yet recruiting
  • Laryngeal Carcinoma
  • LT-SABR
  • IMRT
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 6, 2023

Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I

Not yet recruiting
  • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
  • Phase I dose escalation
  • +3 more
  • Shanghai, Shanghai, China
    Fudan Cancer Hospital
Apr 24, 2023

Alzheimer Trial in Houston (Interleukin-2, Placebo)

Recruiting
  • Alzheimer Disease
  • Houston, Texas
    Houston Methodist Research Institute
Oct 17, 2023

Common Wart Trial (KNP2002, Placebo of KNP2002)

Not yet recruiting
  • Common Wart
  • (no location specified)
May 31, 2023

DOSC and Association With Neighborhood Opportunity: Phase II

Recruiting
  • Pediatric Day of Surgery Cancellations
  • Interview
  • Columbus, Ohio
    Nationwide Children's Hospital
Jul 3, 2023

Metastatic Breast Cancer Trial in Birmingham (Capecitabine Pill)

Not yet recruiting
  • Metastatic Breast Cancer
  • Capecitabine Pill
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 23, 2023

Gastric Cancer, Pancreatic Cancer Trial (LM302+Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • (no location specified)
Jun 28, 2023

Hemorrhage Trial in Fort Worth (0 Hz Control, 0.1 Hz PPT, 0.05 Hz PPT)

Completed
  • Hemorrhage
  • 0 Hz Control
  • +2 more
  • Fort Worth, Texas
    University of North Texas Health Science Center
Aug 1, 2023

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

Not yet recruiting
  • Advanced Solid Tumor
  • Bordeaux, France
    Institut Bergonie
May 24, 2023

Colorectal Cancer Trial (KN046, regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Aug 2, 2023

Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)

Recruiting
  • Breast Cancer
  • Chicago, Illinois
    University of Illinois
Oct 18, 2023

Acute Gout Trial in Wuhan, Linyi, Shanghai (Recombinant Anti-IL-1ß Humanized Monoclonal Antibody Injection 100 mg (phase Ib),

Recruiting
  • Acute Gout
  • Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg (phase Ib)
  • +6 more
  • Wuhan, Hubei, China
  • +2 more
Oct 17, 2022

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)

Not yet recruiting
  • Advanced Salivary Gland Carcinoma
  • Shanghai, China
    Dongmei Ji
Jun 21, 2023

Health Behavior, Health Care Utilization Trial in Eugene (Phase II Promotores de Salud, Phase I Promotores de Salud Outreach)

Active, not recruiting
  • Health Behavior
  • Health Care Utilization
  • Phase II Promotores de Salud
  • Phase I Promotores de Salud Outreach
  • Eugene, Oregon
    University of Oregon
Jan 30, 2023

Gastrointestinal Tumors Trial (Anti-allergic treatment)

Not yet recruiting
  • Gastrointestinal Tumors
  • Anti-allergic treatment
  • (no location specified)
Jun 19, 2023

Cervical Cancer, Endometrial Cancer Trial (Hypofractionated Image guided External Beam Radiation Therapy (EBRT), Cisplatin,

Not yet recruiting
  • Cervical Cancer
  • Endometrial Cancer
  • Hypofractionated Image guided External Beam Radiation Therapy (EBRT)
  • +2 more
  • (no location specified)
May 11, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

Not yet recruiting
  • Adenocarcinoma - GEJ
  • Gastric Adenocarcinoma
  • (no location specified)
Sep 26, 2023

Colorectal Cancer Metastatic Trial in Guangzhou (Fruquintinib)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Colorectal Department,SunYat-sen University Cancer Center
Aug 28, 2023

Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

Not yet recruiting
  • Low Grade Glioma
  • model-guided optimization of treatment plan
  • standard treatment plan, no optimization
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Jul 19, 2023

COPD Trial in Philadelphia (Quercetin)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Philadelphia, Pennsylvania
    Nathaniel Marchetti
Aug 15, 2023

Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

Recruiting
  • Oropharyngeal Cancer
  • Squamous Cell Carcinoma of the Oropharynx
  • Surgery
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
May 30, 2023